{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:03:29Z","timestamp":1783483409499,"version":"3.55.0"},"reference-count":36,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.ajo.2020.03.013","type":"journal-article","created":{"date-parts":[[2020,3,21]],"date-time":"2020-03-21T03:02:10Z","timestamp":1584759730000},"page":"198-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Evaluation of Tear Protein Markers in Dry Eye Disease with Different Lymphotoxin-Alpha Expression Levels"],"prefix":"10.1016","volume":"217","author":[{"given":"Haiyan","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifang","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuxin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2173-7290","authenticated-orcid":false,"given":"Xiaohe","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ajo.2020.03.013_bib1","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.jtos.2017.08.003","article-title":"TFOS DEWS II report executive summary","volume":"15","author":"Craig","year":"2017","journal-title":"Ocul Surf"},{"issue":"2","key":"10.1016\/j.ajo.2020.03.013_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0002-9394(01)01365-4","article-title":"Impaired functional visual acuity of dry eye patients","volume":"133","author":"Goto","year":"2002","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2020.03.013_bib3","first-page":"1356","article-title":"Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells in patients with dry eyes","volume":"41","author":"Brignole","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"10.1016\/j.ajo.2020.03.013_bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ajo.2008.08.032","article-title":"Tear cytokine profiles in dysfunctional tear syndrome","volume":"147","author":"Lam","year":"2009","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2020.03.013_bib5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/mi.2010.26","article-title":"Autoimmunity at the ocular surface: pathogenesis and regulation","volume":"3","author":"Stern","year":"2010","journal-title":"Mucosal Immunol"},{"issue":"4 suppl","key":"10.1016\/j.ajo.2020.03.013_bib6","first-page":"S154","article-title":"Stress-activated protein kinase signaling pathways in dry eye and ocular surface disease","volume":"3","author":"Pflugfelder","year":"2005","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.ajo.2020.03.013_bib7","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1182\/blood-2011-04-325225","article-title":"Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey","volume":"119","author":"Aggarwal","year":"2012","journal-title":"Blood"},{"issue":"10-11","key":"10.1016\/j.ajo.2020.03.013_bib8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.micinf.2013.07.001","article-title":"Controlling herpetic stromal keratitis by modulating lymphotoxin-alpha-mediated inflammatory pathways","volume":"15","author":"Veiga-Parga","year":"2013","journal-title":"Microbes Infect"},{"issue":"6","key":"10.1016\/j.ajo.2020.03.013_bib9","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00011-018-1139-6","article-title":"The role of lymphotoxin-alpha in rheumatoid arthritis","volume":"67","author":"Hirose","year":"2018","journal-title":"Inflamm Res"},{"issue":"4","key":"10.1016\/j.ajo.2020.03.013_bib10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/ar3376","article-title":"Lymphotoxin alpha revisited: general features and implications in rheumatoid arthritis","volume":"13","author":"Calmon-Hamaty","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"10.1016\/j.ajo.2020.03.013_bib11","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s00296-019-04354-0","article-title":"Fatigue in primary Sjogren\u2019s syndrome (pSS) is associated with lower levels of proinflammatory cytokines: a validation study","volume":"39","author":"Davies","year":"2019","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.ajo.2020.03.013_bib12","first-page":"73","article-title":"Experts\u2019 consensus about clinical diagnosis and treatment of dry eye (2013)","volume":"49","year":"2013","journal-title":"Chin J Ophthalmol"},{"key":"10.1016\/j.ajo.2020.03.013_bib13","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1097\/ICO.0b013e318294b0c0","article-title":"Psychometric properties and validation of the Standard Patient Evaluation of Eye Dryness questionnaire","volume":"32","author":"Ngo","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2020.03.013_bib14","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.ajo.2013.04.003","article-title":"Analysis of tear cytokines and clinical correlations in Sj\u00f6gren syndrome dry eye patients and non-Sj\u00f6gren syndrome dry eye patients","volume":"156","author":"Lee","year":"2013","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2020.03.013_bib15","doi-asserted-by":"crossref","first-page":"4556","DOI":"10.1167\/iovs.11-9054","article-title":"Evaluations of tear protein markers in dry eye disease: repeatability of measurement and correlation with disease","volume":"53","author":"Huang","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"4","key":"10.1016\/j.ajo.2020.03.013_bib16","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/ICO.0b013e31803dcda2","article-title":"Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome","volume":"26","author":"Yoon","year":"2007","journal-title":"Cornea"},{"issue":"7","key":"10.1016\/j.ajo.2020.03.013_bib17","first-page":"6","article-title":"ROS, MAPK\/ERK and PKC play distinct roles in EGF-stimulated human corneal cell proliferation and migration","volume":"61","author":"Huo","year":"2015","journal-title":"Cell Mol Biol"},{"issue":"8","key":"10.1016\/j.ajo.2020.03.013_bib18","first-page":"567","article-title":"Therapeutic effects of epidermal growth factor (EGF) combined with plasma cryoprecipitate (CRYO) on the corneal injury induced by paraquat","volume":"30","author":"Guo","year":"2012","journal-title":"Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi"},{"issue":"23","key":"10.1016\/j.ajo.2020.03.013_bib19","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMe0811014","article-title":"Interleukin-1beta and the autoinflammatory diseases","volume":"360","author":"Dinarello","year":"2009","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.ajo.2020.03.013_bib20","first-page":"2283","article-title":"Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease","volume":"42","author":"Solomon","year":"2001","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"10.1016\/j.ajo.2020.03.013_bib21","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1172\/JCI117679","article-title":"Novel production of interleukin-1 receptor antagonist peptides in normal human cornea","volume":"95","author":"Kennedy","year":"1995","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.ajo.2020.03.013_bib22","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.exer.2008.11.019","article-title":"Expression of interleukin-1 receptor antagonist in human cornea","volume":"88","author":"Heur","year":"2009","journal-title":"Exp Eye Res"},{"issue":"2","key":"10.1016\/j.ajo.2020.03.013_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/09273949709085060","article-title":"Secretion of proinflammatory cytokines by human conjunctival epithelial cells","volume":"5","author":"Gamache","year":"1997","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ajo.2020.03.013_bib24","first-page":"330","article-title":"Comparison of topical interleukin-1 vs tumor necrosis factor-alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization, and transplant survival (an American Ophthalmological Society thesis)","volume":"105","author":"Dana","year":"2007","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"2","key":"10.1016\/j.ajo.2020.03.013_bib25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0014-4835(02)00293-2","article-title":"Local suppression of IL-1 by receptor antagonist in the rat model of corneal alkali injury","volume":"76","author":"Yamada","year":"2003","journal-title":"Exp Eye Res"},{"issue":"5","key":"10.1016\/j.ajo.2020.03.013_bib26","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.exer.2008.02.001","article-title":"Topical interleukin-1 receptor antagonist inhibits inflammatory cell infiltration into the cornea","volume":"86","author":"Stapleton","year":"2008","journal-title":"Exp Eye Res"},{"issue":"2","key":"10.1016\/j.ajo.2020.03.013_bib27","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","article-title":"The definition and classification of dry eye disease: report of the definition and classification subcommittee of the international dry eye workshop","volume":"5","year":"2007","journal-title":"Ocul Surf"},{"issue":"3","key":"10.1016\/j.ajo.2020.03.013_bib28","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ajo.2008.05.016","article-title":"Advances in understanding and managing dry eye disease","volume":"146","author":"Lemp","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2020.03.013_bib29","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1097\/01.ico.0000133997.07144.9e","article-title":"The lack of association between signs and symptoms in patients with dry eye disease","volume":"23","author":"Nichols","year":"2004","journal-title":"Cornea"},{"issue":"3","key":"10.1016\/j.ajo.2020.03.013_bib30","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00003226-200404000-00010","article-title":"The repeatability of clinical measurements of dry eye","volume":"23","author":"Nichols","year":"2004","journal-title":"Cornea"},{"issue":"5996","key":"10.1016\/j.ajo.2020.03.013_bib31","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/312724a0","article-title":"Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin","volume":"312","author":"Pennica","year":"1984","journal-title":"Nature"},{"issue":"6047","key":"10.1016\/j.ajo.2020.03.013_bib32","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/318665a0","article-title":"Characterization of receptors for human tumour necrosis factor and their regulation by gamma-interferon","volume":"318","author":"Aggarwal","year":"1985","journal-title":"Nature"},{"issue":"suppl 8","key":"10.1016\/j.ajo.2020.03.013_bib33","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/nri1151","article-title":"Lymphotoxin\/light, lymphoid microenvironments and autoimmune disease","volume":"3","author":"Gommerman","year":"2003","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ajo.2020.03.013_bib34","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1146\/annurev.immunol.23.021704.115719","article-title":"Network communications: lymphotoxins, LIGHT, and TNF","volume":"23","author":"Ware","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ajo.2020.03.013_bib35","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/S0021-9258(18)94104-9","article-title":"Characterization and affinity cross-linking of receptors for human recombinant lymphotoxin (tumor necrosis factor-beta) on a human histiocytic lymphoma cell line","volume":"264","author":"Stauber","year":"1989","journal-title":"J Biol Chem"},{"issue":"suppl 10","key":"10.1016\/j.ajo.2020.03.013_bib36","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1136\/ard.2003.014878","article-title":"True infliximab resistance in rheumatoid arthritis: a role for lymphotoxin alpha?","volume":"63","author":"Buch","year":"2004","journal-title":"Ann Rheum Dis"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939420301136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939420301136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T13:43:28Z","timestamp":1757598208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939420301136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":36,"alternative-id":["S0002939420301136"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2020.03.013","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of Tear Protein Markers in Dry Eye Disease with Different Lymphotoxin-Alpha Expression Levels","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2020.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}